Prognostic significance of elevated troponin i after percutaneous coronary intervention

Califf, 1998, Myonecrosis after revascularization procedures, J Am Coll Cardiol, 31, 241, 10.1016/S0735-1097(97)00506-8 Stone, 2001, Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention, Circulation, 104, 642, 10.1161/hc3101.093902 Holmes, 2001, Troponisms, necrosettes, enzyme leaks, creatinine phosphokinase bumps, and infarctlets, Circulation, 104, 627, 10.1161/01.CIR.104.6.627 2000, Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial, Lancet, 355, 337, 10.1016/S0140-6736(99)11179-6 Newby, 1999, Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes, Am Heart J, 138, 210, 10.1016/S0002-8703(99)70104-3 2001, Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes, Circulation, 103, 1727, 10.1161/01.CIR.103.13.1727 Antman, 1996, Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes, N Engl J Med, 335, 1342, 10.1056/NEJM199610313351802 Ohman, 1996, Cardiac troponin T levels for risk stratification in acute myocardial ischemia, N Engl J Med, 335, 1333, 10.1056/NEJM199610313351801 Talasz, 1992, Side-branch occlusion during percutaneous transluminal coronary angioplasty, Lancet, 339, 1380, 10.1016/0140-6736(92)91198-H Karim, 1995, Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty, Am J Cardiol, 76, 521, 10.1016/S0002-9149(99)80144-1 Rupprecht, 1995, Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina, J Am Coll Cardiol, 26, 1637, 10.1016/0735-1097(95)00371-1 La Vecchia, 1996, Troponin T, troponin I and creatine kinase-MB mass after elective coronary stenting, Coron Artery Dis, 7, 535, 10.1097/00019501-199607000-00008 Genser, 1996, Uncomplicated successful percutaneous transluminal coronary angioplasty does not affect cardiac troponin T plasma concentrations, Am J Cardiol, 78, 127, 10.1016/S0002-9149(97)89225-9 Johansen, 1998, Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements, Eur Heart J, 19, 112, 10.1053/euhj.1997.0732 Shyu, 1998, Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting, Am Heart J, 135, 862, 10.1016/S0002-8703(98)70047-X Bertinchant, 1999, Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris, Am J Cardiol, 84, 51, 10.1016/S0002-9149(99)00191-5 Fuchs, 2000, Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions, Am J Cardiol, 85, 1077, 10.1016/S0002-9149(00)00699-8 Abdelmeguid, 1996, Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions, Circulation, 94, 1528, 10.1161/01.CIR.94.7.1528 Abdelmeguid, 1995, Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure, Circulation, 91, 2733, 10.1161/01.CIR.91.11.2733 Tardiff, 1999, Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention, J Am Coll Cardiol, 33, 88, 10.1016/S0735-1097(98)00551-8 Topol, 1999, Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting, Lancet, 354, 2019, 10.1016/S0140-6736(99)10018-7